BioLineRX Ltd (BLRX)
Score for how it compares with the broader market is near the bottom of its range; company finances score is below the middle, price trend is one of its lowest-scoring factors.
BLRX scores higher than 7% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, BioLineRX Ltd (BLRX) scores 19 out of 100 on the Market Census six-factor composite, which puts it at the Low score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.38× 30-day average
- 52-week range
- 2.15 – 4.16
- Market cap
- $37.82M
- Earnings date
- —
- Volume
- 9,685
- Avg. volume (30d)
- 25,306
- Open
- 2.20
- Previous close
- 2.21
- Day's range (regular session)
- 2.20 – 2.27
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.64
- P/E (TTM)
- —
- EPS (TTM)
- -0.00
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about BLRX right now
BioLineRX Ltd (BLRX) currently scores 19/100 on the Market Census six-factor composite, at the Low score level. BLRX is +0.27% on the day and -6.50% over five sessions as of the most recent tick. Low is the lowest level. Much of BLRX's data reads poorly right now. Market Census does not tell you to short it; the level only describes the data. BLRX's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about BLRX itself. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See BLRX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent BLRX news
Latest headlines that name BioLineRX, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education DayYahoo
- BioLineRx Announces That Two Abstracts Featuring GLIX1 Will Be Presented At The Society For Neuro-Oncology Annual Meeting, November 12-15Benzinga
- BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)Yahoo
- BioLineRx And Hemispherian To Present Preclinical Efficacy Of GLIX1 In Orthotopic Glioblastoma Models, At 21st Meeting Of EANO 2026Benzinga
- BLRX: New GLIX1 Data Touts SynergiesYahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to BLRX’s 19, all within 1 point.
Sorted by closeness to BLRX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.